Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as provides supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. It markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. The company also provides battery-powered and autoclavable bone power tool systems for use in orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries under Hall surgical brand name. In addition, it offers general surgery products, including clinical insufflation systems under AirSeal brand; smoke removal devices under Buffalo Filter brand; endomechanical products, such as tissue retrieval bags, trocars, suction irrigation devices, graspers, scissors, and dissectors used in minimally invasive surgeries; and electrosurgical solution comprising monopolar and bipolar generators, argon beam coagulation generators, handpieces, smoke management systems and other accessories. Further, the company provides endoscopic technologies, including therapeutic and diagnostic products for use in gastroenterology procedures, and products for the treatment of diseases of the dilatation, hemostasis, biliary, structure management, and infection prevention and patient monitoring, including ECG and EEG electrodes, and cardiac defibrillation pads. It markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida. more
Time Frame | CNMD | Sector | S&P500 |
---|---|---|---|
1-Week Return | -4.51% | -3.72% | -0.05% |
1-Month Return | 0.78% | -1.85% | 2.75% |
3-Month Return | -4.86% | -11.4% | 7.4% |
6-Month Return | 1.34% | -4.41% | 10.47% |
1-Year Return | -34.54% | 4.13% | 27.57% |
3-Year Return | -46.06% | 0.3% | 29.56% |
5-Year Return | -36.28% | 36.62% | 89.3% |
10-Year Return | 68.84% | 106.81% | 206.09% |
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | 955.10M | 862.46M | 1.01B | 1.05B | 1.24B | [{"date":"2019-12-31","value":76.73,"profit":true},{"date":"2020-12-31","value":69.29,"profit":true},{"date":"2021-12-31","value":81.19,"profit":true},{"date":"2022-12-31","value":83.99,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Cost of Revenue | 430.38M | 402.16M | 442.60M | 474.23M | 568.50M | [{"date":"2019-12-31","value":75.7,"profit":true},{"date":"2020-12-31","value":70.74,"profit":true},{"date":"2021-12-31","value":77.85,"profit":true},{"date":"2022-12-31","value":83.42,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Gross Profit | 524.72M | 460.30M | 568.04M | 571.25M | 676.25M | [{"date":"2019-12-31","value":77.59,"profit":true},{"date":"2020-12-31","value":68.07,"profit":true},{"date":"2021-12-31","value":84,"profit":true},{"date":"2022-12-31","value":84.47,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Gross Margin | 54.94% | 53.37% | 56.21% | 54.64% | 54.33% | [{"date":"2019-12-31","value":97.74,"profit":true},{"date":"2020-12-31","value":94.96,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":97.21,"profit":true},{"date":"2023-12-31","value":96.66,"profit":true}] |
Operating Expenses | 445.60M | 414.29M | 458.32M | 501.19M | 555.64M | [{"date":"2019-12-31","value":80.2,"profit":true},{"date":"2020-12-31","value":74.56,"profit":true},{"date":"2021-12-31","value":82.48,"profit":true},{"date":"2022-12-31","value":90.2,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Operating Income | 1.60M | (26.97M) | 37.85M | 70.05M | 130.79M | [{"date":"2019-12-31","value":1.23,"profit":true},{"date":"2020-12-31","value":-20.62,"profit":false},{"date":"2021-12-31","value":28.94,"profit":true},{"date":"2022-12-31","value":53.56,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Total Non-Operating Income/Expense | (13.08M) | (88.46M) | (72.10M) | (169.82M) | (89.67M) | [{"date":"2019-12-31","value":-1307900000,"profit":false},{"date":"2020-12-31","value":-8845900000,"profit":false},{"date":"2021-12-31","value":-7209700000,"profit":false},{"date":"2022-12-31","value":-16982100000,"profit":false},{"date":"2023-12-31","value":-8967200000,"profit":false}] |
Pre-Tax Income | 31.23M | 1.60M | 73.11M | (70.86M) | 80.83M | [{"date":"2019-12-31","value":38.63,"profit":true},{"date":"2020-12-31","value":1.98,"profit":true},{"date":"2021-12-31","value":90.45,"profit":true},{"date":"2022-12-31","value":-87.67,"profit":false},{"date":"2023-12-31","value":100,"profit":true}] |
Income Taxes | 2.60M | (7.91M) | 10.56M | 9.72M | 16.37M | [{"date":"2019-12-31","value":15.91,"profit":true},{"date":"2020-12-31","value":-48.35,"profit":false},{"date":"2021-12-31","value":64.53,"profit":true},{"date":"2022-12-31","value":59.38,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Income After Taxes | 28.62M | 9.52M | 62.54M | (80.58M) | 64.46M | [{"date":"2019-12-31","value":44.4,"profit":true},{"date":"2020-12-31","value":14.76,"profit":true},{"date":"2021-12-31","value":97.03,"profit":true},{"date":"2022-12-31","value":-125.01,"profit":false},{"date":"2023-12-31","value":100,"profit":true}] |
Income From Continuous Operations | 28.62M | 9.52M | 62.54M | (80.58M) | 57.97M | [{"date":"2019-12-31","value":45.76,"profit":true},{"date":"2020-12-31","value":15.22,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-128.84,"profit":false},{"date":"2023-12-31","value":92.69,"profit":true}] |
Income From Discontinued Operations | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Net Income | 28.62M | 9.52M | 62.54M | (80.58M) | 64.46M | [{"date":"2019-12-31","value":44.4,"profit":true},{"date":"2020-12-31","value":14.76,"profit":true},{"date":"2021-12-31","value":97.03,"profit":true},{"date":"2022-12-31","value":-125.01,"profit":false},{"date":"2023-12-31","value":100,"profit":true}] |
EPS (Diluted) | 2.65 | 2.16 | 3.21 | 2.65 | 3.45 | [{"date":"2019-12-31","value":76.81,"profit":true},{"date":"2020-12-31","value":62.61,"profit":true},{"date":"2021-12-31","value":93.04,"profit":true},{"date":"2022-12-31","value":76.81,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
These ratios help you determine the liquidity of the company. Higher is better.
CNMD | |
---|---|
Cash Ratio | 0.14 |
Current Ratio | 2.27 |
Quick Ratio | 1.06 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
CNMD | |
---|---|
ROA (LTM) | 3.98% |
ROE (LTM) | 15.24% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
CNMD | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 0.60 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.40 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
CNMD | |
---|---|
Trailing PE | 16.90 |
Forward PE | 27.03 |
P/S (TTM) | 1.71 |
P/B | 2.40 |
Price/FCF | 46 |
EV/R | 2.44 |
EV/Ebitda | 11.65 |
PEG | 5.29 |
CONMED Corporation (CNMD) share price today is $71.32
Yes, Indians can buy shares of CONMED Corporation (CNMD) on Vested. To buy CONMED Corporation from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in CNMD stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of CONMED Corporation (CNMD) via the Vested app. You can start investing in CONMED Corporation (CNMD) with a minimum investment of $1.
You can invest in shares of CONMED Corporation (CNMD) via Vested in three simple steps:
The 52-week high price of CONMED Corporation (CNMD) is $113.91. The 52-week low price of CONMED Corporation (CNMD) is $60.72.
The price-to-earnings (P/E) ratio of CONMED Corporation (CNMD) is 17.1919
The price-to-book (P/B) ratio of CONMED Corporation (CNMD) is 2.40
The dividend yield of CONMED Corporation (CNMD) is 1.12%
The market capitalization of CONMED Corporation (CNMD) is $2.24B
The stock symbol (or ticker) of CONMED Corporation is CNMD